Mauro Felippe Felix Mediano

Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study

Alejandro Marcel Hasslocher‐Moreno, Roberto Magalhães Saraiva, Luiz Henrique Conde Sangenis et al. · EClinicalMedicine · 2020 · 67 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole

Gilberto Marcelo Sperandio da Silva, Mauro Felippe Felix Mediano, Pedro Emmanuel Alvarenga Americano do Brasil et al. · Antimicrobial Agents and Chemotherapy · 2014 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges

Aline Xavier Frota, Marcelo Carvalho Vieira, Carla Soares et al. · Revista da Sociedade Brasileira de Medicina Tropical · 2021 · 46 citations · Full text

Medicine, Infectious Diseases, Rehabilitation Medicine +11

Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study

Mauro Felippe Felix Mediano, Fernanda de Souza Nogueira Sardinha Mendes, Vivian Liane Mattos Pinto et al. · Revista da Sociedade Brasileira de Medicina Tropical · 2016 · 43 citations · Full text

Medicine, Cardiology, Rehabilitation Medicine +17

Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease

Gilberto Marcelo Sperandio da Silva, Mauro Felippe Felix Mediano, Alejandro Marcel Hasslocher‐Moreno et al. · Journal of Antimicrobial Chemotherapy · 2017 · 40 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14